Selective vulnerability in alzheimer's disease: amyloid precursor protein and p75NTR interaction

Annals of Neurology

Volumn 65, Issue 3, 2009, Pages 294-303

  Fombonne, Joanna ^a,b   Rabizadeh, Shahrooz ^a   Banwait, Surita ^a   Mehlen, Patrick ^a,b   Bredesen, Dale E ^a,c,d  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR P75;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE;

EID: 65249105453     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21578     Document Type: Article

References (30)

1. Woolf NJ, Gould E, Butcher LL. Nerve growth factor receptor is associated with cholinergic neurons of the basal forebrain but not the pontomesencephalon. Neuroscience 1989; 30:143-152.
2. Whitehouse PJ, Price DL, Clark AW, et al. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981;10:122-126.
3. Mufson EJ, Bothwell M, Kordower JH. Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain. Exp Neurol 1989;105:221-232.
4. Barrett GL, Bartlett PF. The p75 nerve growth factor receptor mediates survival or death depending on the stage of sensory neuron development. Proc Natl Acad Sci U S A 1994;91: 6501-6505.
5. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 1996;383: 716-719.
6. Frade JM, Rodriguez-Tebar A, Barde YA. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 1996;383:166-168.
7. Rabizadeh S, Bitler CM, Butcher LL, Bredesen DE. Expression of the low-affinity nerve growth factor receptor enhances betaamyloid peptide toxicity. Proc Natl Acad Sci U S A 1994;91: 10703-10706.
8. Kuner P, Schubenel R, Hertel C. Beta-amyloid binds to p57NTR and activates NFkappaB in human neuroblastoma cells. J Neurosci Res 1998;54:798-804.
9. Yaar M, Zhai S, Pilch PF, et al. Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J Clin Invest 1997;100: 2333-2340.
10. Pedraza CE, Podlesniy P, Vidal N, et al. Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR. Am J Pathol 2005; 166:533-543.
11. Longo FM, Massa SM. Neurotrophin receptor-based strategies for Alzheimer's disease. Curr Alzheimer Res 2005;2:167-169.
12. Yaar M, Zhai S, Panova I, et al. A cyclic peptide that binds p75(NTR) protects neurones from beta amyloid (1-40)- induced cell death. Neuropathol Appl Neurobiol 2007;33: 533-543.
13. Lu DC, Shaked GM, Masliah E, et al. Amyloid beta protein toxicity mediated by the formation of amyloid-beta protein precursor complexes. Ann Neurol 2003;54:781-789.
14. Shaked GM, Kummer MP, Lu DC, et al. Abeta induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624). Faseb J 2006;20:1254-1256.
15. Galvan V, Gorostiza OF, Banwait S, et al. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci U S A 2006;103:7130-7135.
16. Saganich MJ, Schroeder BE, Galvan V, et al. Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP. J Neurosci 2006;26:13428-13436.
17. Galvan V, Zhang J, Gorostiza OF, et al. Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664. Behav Brain Res 2008;191: 246-255.
18. Nguyen TV, Galvan V, Huang W, et al. Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664. J Neurochem 2008;104: 1065-1080.
19. Lu DC, Rabizadeh S, Chandra S, et al. A second cytotoxic proteolytic peptide derived from amyloid b-protein precursor. Nat Med 2000;6:397-404.
20. Ye X, Mehlen P, Rabizadeh S, et al. TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction. J Biol Chem 1999;274:30202-30208.
21. Llambi F, Causeret F, Bloch-Gallego E, Mehlen P. Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. Embo J 2001;20:2715-2722.
22. Cao X, Sudhof TC. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 2001;293:115-120.
23. Ting AT, Pimentel-Muinos FX, Seed B. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. Embo J 1996;15:6189-6196.
24. Koo EH, Squazzo SL. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 1994;269:17386-17389.
25. Mehlen P, Rabizadeh S, Snipas SJ, et al. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 1998;395:801-804.
26. Ninomiya H, Roch JM, Jin LW, Saitoh T. Secreted form of amyloid beta/A4 protein precursor (APP) binds to two distinct APP binding sites on rat B103 neuron-like cells through two different domains, but only one site is involved in neuritotropic activity. J Neurochem 1994;63:495-500.
27. Felsenstein KM, Hunihan LW, Roberts SB. Altered cleavage and secretion of a recombinant beta-APP bearing the Swedish familial Alzheimer's disease mutation. Nat Genet 1994;6:251-255.
28. Van Vickle GD, Esh CL, Kalback WM, et al. TgCRND8 amyloid precursor protein transgenic mice exhibit an altered gamma-secretase processing and an aggressive, additive amyloid pathology subject to immunotherapeutic modulation. Biochemistry 2007;46:10317-10327.
29. Cao X, Sudhof TC. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 2001;293:115-120.
30. Wiley JC, Smith EA, Hudson MP, et al. Fe65 stimulates proteolytic liberation of the beta-amyloid precursor protein intracellular domain. J Biol Chem 2007;282:33313-33325.